Denver

Colorado Governor Signs Prescription Drug Cost Control Law to Aid Rural Healthcare and Increase Transparency

AI Assisted Icon
Published on June 03, 2025
Colorado Governor Signs Prescription Drug Cost Control Law to Aid Rural Healthcare and Increase TransparencySource: xiquinhosilva, CC BY 2.0, via Wikimedia Commons

Coloradans are set to see lower prescription drug prices as the Governor inked new legislation on Friday aimed at reining in costs and boosting transparency. The law, backed by Senate President Pro Tempore Dafna Michaelson Jenet, D-Commerce City, and Representative Matthew Martinez, D-Monte Vista, targets protections for rural hospitals, pharmacies, and providers that many rely on for essential health services.

"Colorado families are counting on us to put their health and safety first," Michaelson Jenet stated, indicating the pivotal role the law plays in supporting rural communities' access to health services. Martinez echoed this sentiment, highlighting the necessity for rural and underserved populations to receive needed prescription drugs without exorbitant costs or restrictions from pharmaceutical companies, especially those dependent on the federal 340B program. "This bipartisan law ensures that pharmaceutical companies do not impose restrictions on the local pharmacies, clinics and safety net providers that are dependent on the federal 340B program and serve our rural communities," Martinez said, as per Colorado Senate Democrats

Rep. Kyle Brown, D-Louisville, Chair of the House Health & Human Services Committee, addressed the longstanding need for transparency and accountability within the 340B program and the pharmaceutical industry's profit margins. "The federal 340B program has needed additional transparency and accountability for some time, and pharmaceutical companies have continued to rake in profits," said Brown, as obtained by Colorado Senate Democrats. The new legislation, SB25-071, cosponsored by Senator Janice Rich, R-Grand Junction, and Representative Rick Taggart, D-Grand Junction, prevents prescription drug manufacturers from imposing restrictions on facilities benefitting from the 340B Drug Pricing Program, enhancing overall healthcare affordability and access in Colorado.

In addition to legislating pricing controls, SB25-071 mandates hospitals to disclose in their annual reports how they have utilized the 340B savings, aiming for increased transparency. Nearly 89 percent of Colorado's rural hospitals operate under financially challenging conditions. The new law will not only reduce the burden of prescription drug costs but also safeguard free clinics and vaccines essential for maintaining public health. To align the 340B savings with consumer benefits rather than administrative overhead, the law specifically prohibits hospitals from spending these savings on executive salaries, gifts, lobbying, and advertising. "We've taken steps to lower health care costs for Coloradans. By improving transparency and accountability, we are continuing to take steps to expand access so that more Coloradans can receive high-quality health care," said Brown, as noted by Colorado Senate Democrats.